New negative-pressure wound device hits the market

The FDA has cleared Smith & Nephew to sell its single-use Pico device for treating wounds in the U.S.

The agency approved the negative-pressure wound therapy device for use in homes as well as hospitals, according to a Smith & Nephew news release.

Negative-pressure wound therapy uses dressing and a vacuum pump to apply sub-atmospheric pressure to burns and other skin wounds. Smith & Nephew said its new entry in the category can treat a wide range of patients who have undergone orthopedic, plastic and general surgery procedures.

The Pico is pocket-sized and has a seven-day duration, according to the company.




 


Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup